Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130455
Status:
TERMINATED
Last Update Posted:
2007-02-06
First Post:
2005-08-12
Brief Title:
Treatment of Depression in the Elderly
Sponsor:
Psychiatric Hospital Hillerod
Organization:
Psychiatric Hospital Hillerod
Study Overview
Official Title:
A 12 Week Multi-Centre Randomized Double-Blind Placebo Controlled Evaluation of the Most Efficacious and Tolerable Dose of Escitalopram in the Treatment of Elderly Patients
Status:
TERMINATED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study is designed to establish the efficacy and tolerability of escitalopram in the treatment of depressive episodes of mild to moderate severity in the elderly
The study is designed as a mainly naturalistic study including all patients of 65 years of age or above that judged by the clinician would benefit from treatment by an antidepressant medication The study is designed as a double-blind randomised placebo controlled study with two groups of active treatment escitalopram in two doses 5 or 10 mg daily in a twelve week period
The study is designed as a mainly naturalistic study including all patients of 65 years of age or above that judged by the clinician would benefit from treatment by an antidepressant medication The study is designed as a double-blind randomised placebo controlled study with two groups of active treatment escitalopram in two doses 5 or 10 mg daily in a twelve week period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None